STAT3 and neoplasm: Our data suggest that inhibiting the Ref‐1–STAT3 axis leads to a transcriptional reprogramming in tumour and/or microenvironment through alterations in effector proteins and will make an impact on the pathways regulated by these proteins, for example proliferation, invasion and response to hypoxic conditions.3, 58